nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.159	0.199	CbGbCtD
Sulfadiazine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.106	0.133	CbGbCtD
Sulfadiazine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0973	0.122	CbGbCtD
Sulfadiazine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0973	0.122	CbGbCtD
Sulfadiazine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0747	0.0936	CbGbCtD
Sulfadiazine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0738	0.0924	CbGbCtD
Sulfadiazine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0504	0.0632	CbGbCtD
Sulfadiazine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0481	0.0603	CbGbCtD
Sulfadiazine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0429	0.0537	CbGbCtD
Sulfadiazine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0252	0.0315	CbGbCtD
Sulfadiazine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0238	0.0298	CbGbCtD
Sulfadiazine—Diuresis—Aminophylline—chronic obstructive pulmonary disease	0.00814	0.0586	CcSEcCtD
Sulfadiazine—Skin necrosis—Aminophylline—chronic obstructive pulmonary disease	0.00722	0.052	CcSEcCtD
Sulfadiazine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.003	0.0508	CbGpPWpGaD
Sulfadiazine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00265	0.0449	CbGpPWpGaD
Sulfadiazine—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00241	0.0173	CcSEcCtD
Sulfadiazine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00217	0.0368	CbGpPWpGaD
Sulfadiazine—Skin discolouration—Formoterol—chronic obstructive pulmonary disease	0.00213	0.0153	CcSEcCtD
Sulfadiazine—Skin discolouration—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.0153	CcSEcCtD
Sulfadiazine—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00211	0.0152	CcSEcCtD
Sulfadiazine—Polyuria—Aminophylline—chronic obstructive pulmonary disease	0.00209	0.015	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00194	0.014	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.00189	0.0136	CcSEcCtD
Sulfadiazine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00185	0.0312	CbGpPWpGaD
Sulfadiazine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00171	0.029	CbGpPWpGaD
Sulfadiazine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00168	0.0284	CbGpPWpGaD
Sulfadiazine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.0015	0.0254	CbGpPWpGaD
Sulfadiazine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.0107	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00143	0.0103	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.0103	CcSEcCtD
Sulfadiazine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00139	0.0236	CbGpPWpGaD
Sulfadiazine—Neuritis—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.01	CcSEcCtD
Sulfadiazine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00137	0.0231	CbGpPWpGaD
Sulfadiazine—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00971	CcSEcCtD
Sulfadiazine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00134	0.0227	CbGpPWpGaD
Sulfadiazine—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.00934	CcSEcCtD
Sulfadiazine—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00891	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00123	0.00885	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00885	CcSEcCtD
Sulfadiazine—CYP2E1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00123	0.0208	CbGpPWpGaD
Sulfadiazine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.00879	CcSEcCtD
Sulfadiazine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00122	0.0207	CbGpPWpGaD
Sulfadiazine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00844	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00839	CcSEcCtD
Sulfadiazine—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00833	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00794	CcSEcCtD
Sulfadiazine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0011	0.0187	CbGpPWpGaD
Sulfadiazine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00109	0.0185	CbGpPWpGaD
Sulfadiazine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00772	CcSEcCtD
Sulfadiazine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00768	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00751	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00742	CcSEcCtD
Sulfadiazine—CYP2E1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00103	0.0174	CbGpPWpGaD
Sulfadiazine—Neuritis—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00728	CcSEcCtD
Sulfadiazine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000995	0.00716	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000994	0.00715	CcSEcCtD
Sulfadiazine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000993	0.0168	CbGpPWpGaD
Sulfadiazine—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000989	0.00711	CcSEcCtD
Sulfadiazine—CYP2E1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000987	0.0167	CbGpPWpGaD
Sulfadiazine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000956	0.00688	CcSEcCtD
Sulfadiazine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000945	0.0068	CcSEcCtD
Sulfadiazine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00094	0.00676	CcSEcCtD
Sulfadiazine—Sulfamethazine—ALB—chronic obstructive pulmonary disease	0.000934	0.241	CrCbGaD
Sulfadiazine—Dapsone—MPO—chronic obstructive pulmonary disease	0.00093	0.24	CrCbGaD
Sulfadiazine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000924	0.00665	CcSEcCtD
Sulfadiazine—Sulfamerazine—ALB—chronic obstructive pulmonary disease	0.000912	0.235	CrCbGaD
Sulfadiazine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.0009	0.00648	CcSEcCtD
Sulfadiazine—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000893	0.00643	CcSEcCtD
Sulfadiazine—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000891	0.0151	CbGpPWpGaD
Sulfadiazine—CYP2C8—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000887	0.015	CbGpPWpGaD
Sulfadiazine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000886	0.00637	CcSEcCtD
Sulfadiazine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000858	0.00618	CcSEcCtD
Sulfadiazine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000858	0.00617	CcSEcCtD
Sulfadiazine—CYP2C8—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000853	0.0144	CbGpPWpGaD
Sulfadiazine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000851	0.00612	CcSEcCtD
Sulfadiazine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00085	0.00612	CcSEcCtD
Sulfadiazine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000849	0.00611	CcSEcCtD
Sulfadiazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000846	0.00609	CcSEcCtD
Sulfadiazine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000845	0.0143	CbGpPWpGaD
Sulfadiazine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000817	0.00588	CcSEcCtD
Sulfadiazine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000814	0.00586	CcSEcCtD
Sulfadiazine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000802	0.00577	CcSEcCtD
Sulfadiazine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000783	0.00563	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00078	0.00561	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000774	0.00557	CcSEcCtD
Sulfadiazine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000768	0.00553	CcSEcCtD
Sulfadiazine—CYP2E1—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000745	0.0126	CbGpPWpGaD
Sulfadiazine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000736	0.0053	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000733	0.00527	CcSEcCtD
Sulfadiazine—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000722	0.0122	CbGpPWpGaD
Sulfadiazine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000722	0.00519	CcSEcCtD
Sulfadiazine—CYP2E1—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000717	0.0121	CbGpPWpGaD
Sulfadiazine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000715	0.00515	CcSEcCtD
Sulfadiazine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000715	0.00514	CcSEcCtD
Sulfadiazine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000715	0.00514	CcSEcCtD
Sulfadiazine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000713	0.00513	CcSEcCtD
Sulfadiazine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000712	0.00512	CcSEcCtD
Sulfadiazine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000712	0.00512	CcSEcCtD
Sulfadiazine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000712	0.00512	CcSEcCtD
Sulfadiazine—Sulfamethizole—ALB—chronic obstructive pulmonary disease	0.000707	0.182	CrCbGaD
Sulfadiazine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.0007	0.00504	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000694	0.005	CcSEcCtD
Sulfadiazine—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000694	0.0118	CbGpPWpGaD
Sulfadiazine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000685	0.00493	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000685	0.00493	CcSEcCtD
Sulfadiazine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00486	CcSEcCtD
Sulfadiazine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000675	0.00485	CcSEcCtD
Sulfadiazine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000671	0.00483	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000671	0.00483	CcSEcCtD
Sulfadiazine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000671	0.0114	CbGpPWpGaD
Sulfadiazine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000663	0.00477	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000657	0.00473	CcSEcCtD
Sulfadiazine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000656	0.00472	CcSEcCtD
Sulfadiazine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000655	0.0111	CbGpPWpGaD
Sulfadiazine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000647	0.00466	CcSEcCtD
Sulfadiazine—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000644	0.0109	CbGpPWpGaD
Sulfadiazine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00064	0.0046	CcSEcCtD
Sulfadiazine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000637	0.00458	CcSEcCtD
Sulfadiazine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000626	0.0045	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000624	0.00449	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000624	0.00449	CcSEcCtD
Sulfadiazine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.00446	CcSEcCtD
Sulfadiazine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00062	0.00446	CcSEcCtD
Sulfadiazine—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00062	0.0105	CbGpPWpGaD
Sulfadiazine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00444	CcSEcCtD
Sulfadiazine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000616	0.00443	CcSEcCtD
Sulfadiazine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000613	0.00441	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000611	0.0044	CcSEcCtD
Sulfadiazine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000607	0.00437	CcSEcCtD
Sulfadiazine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000601	0.00432	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000592	0.00426	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000592	0.00426	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000589	0.00424	CcSEcCtD
Sulfadiazine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000585	0.00421	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000579	0.00417	CcSEcCtD
Sulfadiazine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000572	0.00412	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00057	0.0041	CcSEcCtD
Sulfadiazine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000569	0.0041	CcSEcCtD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000569	0.00963	CbGpPWpGaD
Sulfadiazine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000568	0.00408	CcSEcCtD
Sulfadiazine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000567	0.00408	CcSEcCtD
Sulfadiazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000564	0.00406	CcSEcCtD
Sulfadiazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00405	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00056	0.00403	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00056	0.00403	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.00402	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000549	0.00395	CcSEcCtD
Sulfadiazine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000544	0.00392	CcSEcCtD
Sulfadiazine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000544	0.00392	CcSEcCtD
Sulfadiazine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000542	0.0039	CcSEcCtD
Sulfadiazine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000542	0.0039	CcSEcCtD
Sulfadiazine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000542	0.0039	CcSEcCtD
Sulfadiazine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000542	0.0039	CcSEcCtD
Sulfadiazine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00054	0.00388	CcSEcCtD
Sulfadiazine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.00385	CcSEcCtD
Sulfadiazine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.00385	CcSEcCtD
Sulfadiazine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000535	0.00385	CcSEcCtD
Sulfadiazine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000533	0.00384	CcSEcCtD
Sulfadiazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000532	0.00383	CcSEcCtD
Sulfadiazine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000531	0.00382	CcSEcCtD
Sulfadiazine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000531	0.00382	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00381	CcSEcCtD
Sulfadiazine—CYP2E1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000527	0.00892	CbGpPWpGaD
Sulfadiazine—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000524	0.00888	CbGpPWpGaD
Sulfadiazine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000518	0.00877	CbGpPWpGaD
Sulfadiazine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.0037	CcSEcCtD
Sulfadiazine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.00368	CcSEcCtD
Sulfadiazine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.00368	CcSEcCtD
Sulfadiazine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00363	CcSEcCtD
Sulfadiazine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00363	CcSEcCtD
Sulfadiazine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000504	0.00363	CcSEcCtD
Sulfadiazine—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000504	0.00854	CbGpPWpGaD
Sulfadiazine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000496	0.0084	CbGpPWpGaD
Sulfadiazine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00356	CcSEcCtD
Sulfadiazine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.00349	CcSEcCtD
Sulfadiazine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000485	0.00349	CcSEcCtD
Sulfadiazine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00343	CcSEcCtD
Sulfadiazine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000476	0.00806	CbGpPWpGaD
Sulfadiazine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00342	CcSEcCtD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000472	0.00799	CbGpPWpGaD
Sulfadiazine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000469	0.00337	CcSEcCtD
Sulfadiazine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000469	0.00337	CcSEcCtD
Sulfadiazine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000465	0.00335	CcSEcCtD
Sulfadiazine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000459	0.0033	CcSEcCtD
Sulfadiazine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00329	CcSEcCtD
Sulfadiazine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000458	0.00775	CbGpPWpGaD
Sulfadiazine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.00319	CcSEcCtD
Sulfadiazine—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000436	0.00738	CbGpPWpGaD
Sulfadiazine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00313	CcSEcCtD
Sulfadiazine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00313	CcSEcCtD
Sulfadiazine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00311	CcSEcCtD
Sulfadiazine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00311	CcSEcCtD
Sulfadiazine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00311	CcSEcCtD
Sulfadiazine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00311	CcSEcCtD
Sulfadiazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000429	0.00309	CcSEcCtD
Sulfadiazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000429	0.00309	CcSEcCtD
Sulfadiazine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00307	CcSEcCtD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000426	0.00721	CbGpPWpGaD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000426	0.00721	CbGpPWpGaD
Sulfadiazine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000423	0.00304	CcSEcCtD
Sulfadiazine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000423	0.00304	CcSEcCtD
Sulfadiazine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000422	0.00303	CcSEcCtD
Sulfadiazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00042	0.00303	CcSEcCtD
Sulfadiazine—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00042	0.00712	CbGpPWpGaD
Sulfadiazine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000414	0.00298	CcSEcCtD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000413	0.007	CbGpPWpGaD
Sulfadiazine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00296	CcSEcCtD
Sulfadiazine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000409	0.00294	CcSEcCtD
Sulfadiazine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00294	CcSEcCtD
Sulfadiazine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00293	CcSEcCtD
Sulfadiazine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00293	CcSEcCtD
Sulfadiazine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00293	CcSEcCtD
Sulfadiazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.00292	CcSEcCtD
Sulfadiazine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00287	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—ALB—chronic obstructive pulmonary disease	0.000397	0.102	CrCbGaD
Sulfadiazine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000397	0.00672	CbGpPWpGaD
Sulfadiazine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000394	0.00283	CcSEcCtD
Sulfadiazine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00277	CcSEcCtD
Sulfadiazine—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000383	0.00648	CbGpPWpGaD
Sulfadiazine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00272	CcSEcCtD
Sulfadiazine—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000377	0.00638	CbGpPWpGaD
Sulfadiazine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000376	0.00637	CbGpPWpGaD
Sulfadiazine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000371	0.00267	CcSEcCtD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000368	0.00623	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000363	0.00615	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000347	0.00587	CbGpPWpGaD
Sulfadiazine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000346	0.00586	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000345	0.00585	CbGpPWpGaD
Sulfadiazine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000336	0.00241	CcSEcCtD
Sulfadiazine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000333	0.00563	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000311	0.00527	CbGpPWpGaD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00031	0.00524	CbGpPWpGaD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00031	0.00524	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000307	0.00519	CbGpPWpGaD
Sulfadiazine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000305	0.00517	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.0003	0.00507	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000298	0.00505	CbGpPWpGaD
Sulfadiazine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000297	0.00214	CcSEcCtD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000296	0.00501	CbGpPWpGaD
Sulfadiazine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.00212	CcSEcCtD
Sulfadiazine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00206	CcSEcCtD
Sulfadiazine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00202	CcSEcCtD
Sulfadiazine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.00197	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00027	0.00194	CcSEcCtD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000268	0.00453	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000264	0.00447	CbGpPWpGaD
Sulfadiazine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00185	CcSEcCtD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000252	0.00427	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000251	0.00425	CbGpPWpGaD
Sulfadiazine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000246	0.00177	CcSEcCtD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000244	0.00414	CbGpPWpGaD
Sulfadiazine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00175	CcSEcCtD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000243	0.00411	CbGpPWpGaD
Sulfadiazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00169	CcSEcCtD
Sulfadiazine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00168	CcSEcCtD
Sulfadiazine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00168	CcSEcCtD
Sulfadiazine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.00167	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000221	0.00374	CbGpPWpGaD
Sulfadiazine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00159	CcSEcCtD
Sulfadiazine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.00159	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000218	0.00369	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00369	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000217	0.00367	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000215	0.00364	CbGpPWpGaD
Sulfadiazine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00154	CcSEcCtD
Sulfadiazine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00153	CcSEcCtD
Sulfadiazine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00153	CcSEcCtD
Sulfadiazine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000202	0.00342	CbGpPWpGaD
Sulfadiazine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00143	CcSEcCtD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000198	0.00335	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000195	0.0033	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000191	0.00323	CbGpPWpGaD
Sulfadiazine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00137	CcSEcCtD
Sulfadiazine—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000189	0.00319	CbGpPWpGaD
Sulfadiazine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00133	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00311	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.00306	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.00301	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000177	0.00299	CbGpPWpGaD
Sulfadiazine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00123	CcSEcCtD
Sulfadiazine—Rash—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00122	CcSEcCtD
Sulfadiazine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00122	CcSEcCtD
Sulfadiazine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00122	CcSEcCtD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00016	0.00271	CbGpPWpGaD
Sulfadiazine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00115	CcSEcCtD
Sulfadiazine—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000159	0.00268	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.00265	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000155	0.00263	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000153	0.0026	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000153	0.00259	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000151	0.00255	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.00243	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.0024	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000141	0.00238	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000139	0.00235	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000134	0.00227	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.00226	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000132	0.00224	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.00223	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00013	0.00221	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000129	0.00218	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.00215	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000122	0.00206	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00012	0.00203	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00197	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00195	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00192	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000109	0.00185	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000108	0.00182	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000107	0.00182	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000106	0.0018	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000102	0.00173	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000101	0.00171	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.89e-05	0.00167	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.75e-05	0.00165	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.38e-05	0.00159	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	9.27e-05	0.00157	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.25e-05	0.00157	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.51e-05	0.00144	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.39e-05	0.00142	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	7.54e-05	0.00128	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.1e-05	0.0012	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.1e-05	0.0012	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7e-05	0.00119	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	6.91e-05	0.00117	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.61e-05	0.00112	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.52e-05	0.0011	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.43e-05	0.00109	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.42e-05	0.00109	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.18e-05	0.00105	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.14e-05	0.00104	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.1e-05	0.00103	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.09e-05	0.00103	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	5.97e-05	0.00101	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.55e-05	0.00094	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.38e-05	0.000911	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5e-05	0.000846	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.97e-05	0.000842	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.96e-05	0.000839	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.86e-05	0.000823	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.52e-05	0.000765	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.42e-05	0.000749	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.77e-05	0.000639	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.73e-05	0.000632	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.6e-05	0.00061	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.4e-05	0.000577	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.3e-05	0.000558	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.26e-05	0.000552	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.23e-05	0.000546	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.21e-05	0.000543	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.14e-05	0.000531	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.01e-05	0.000509	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.98e-05	0.000505	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.94e-05	0.000498	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.71e-05	0.000459	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.66e-05	0.00045	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.62e-05	0.000444	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.62e-05	0.000443	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.58e-05	0.000437	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.45e-05	0.000414	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.4e-05	0.000407	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.4e-05	0.000406	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.28e-05	0.000386	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.26e-05	0.000383	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.23e-05	0.000378	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.21e-05	0.000374	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.08e-05	0.000352	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.97e-05	0.000334	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.84e-05	0.000312	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.82e-05	0.000307	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.75e-05	0.000297	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.73e-05	0.000293	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.69e-05	0.000286	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.000271	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.58e-05	0.000267	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.55e-05	0.000262	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.48e-05	0.000251	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.46e-05	0.000246	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.34e-05	0.000227	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.000217	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.21e-05	0.000206	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.2e-05	0.000203	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.12e-05	0.000189	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.09e-05	0.000185	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.000179	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.000177	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.19e-06	0.000122	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.88e-06	0.000116	CbGpPWpGaD
